To the extent possible under law, the person who associated CC0 with this work has waived all copyright and related or neighboring rights to this work.
DRAVP ID DRAVPa2493
Peptide Name Sequence 4 from Patent CN117377679A
Sequence KQNSGDSKV
Sequence Length 9
Source Synthetic construct
Target Organism SARS-CoV-2
Patent Type Patent Application
Publication Date 2024-01-09
Patent No CN117377679A
Family Info WO 2022/242432 A1, US 2022/0370604 A1, TW 202300513 A, CN 117377679 A, EP 4341274 A1, JP 2024517927 A
Patent Title Peptide vaccines against viral infection
Comment
Abstract The present invention relates to an immunogenic composition for resisting viral infection, and in particular, to an immunogenic composition having a peptide capable of binding to a molecule of the major histocompatibility complex (MHC) and inducing a broad-acting immunity against coronavirus, and more particularly, to an immunogenic composition having a peptide capable of binding to the molecule of the major histocompatibility complex (MHC).
To the extent possible under law, the person who associated CC0 with this work has waived all copyright and related or neighboring rights to this work.